Verapamil has been shown to be effective in the management of supraventricular tachycardia (SVT). However, the utility of verapamil may be limited because of adverse effects, specifically hypotension. Several clinical observations have shown that the intravenous administration of calcium is effective in reversing the myocardial depressant effects of verapamil. We report the case of a patient with SVT and a systolic blood pressure of 80 mm Hg in which the administration of calcium chloride prior to that of verapamil may have negated verapamil-induced hypotension.
Get full access to this article
View all access options for this article.
References
1.
SchamrothLKriklerDMGarrettC. Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J1972; 1: 660–2.
2.
SungRJElserBMcAllisterRG. Intravenous verapamil for termination of re-entrant supraventricular tachycardias. Ann Intern Med1980; 93: 682–9.
3.
RinkenbergerRLPrystowskyENHegerJJ. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation1980; 62: 996–1010.
4.
SinghBNRocheAH. Effects of intravenous verapamil on hemodynamics in patients with heart disease. Am Heart J1977; 94: 593–9.
5.
MorrisDLGoldschlagerN. Calcium infusion for reversal of adverse effects of intravenous verapamil. JAMA1983; 249: 3212–3.
6.
HattoriVTMandelWJPeterT. Calcium for myocardial depression from verapamil (letter). N Engl J Med1982; 306: 238.
7.
HaftJIHabbabMA. Treatment of atrial arrhythmias, effectiveness of verapamil when preceded by calcium infusion. Arch Intern Med1986; 146: 1085–9.
8.
CarrascoHAFuenmayorABarbozaJS. Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome. Am Heart J1978; 96: 760–1.
9.
SinghBNColettJTChewCY. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prof Cardiovasc Dis1980; 22: 243–301.
